Butterfly Network, Inc. (BFLY) is a publicly traded Healthcare sector company. As of October 27, 2026, BFLY trades at $6.98 with a market cap of $1.80B and a P/E ratio of -31.98. BFLY moved +5.78% today. Year to date, BFLY is +77.60%; over the trailing twelve months it is +198.66%. Its 52-week range spans $1.32 to $10.21. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces BFLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bridge Neurotech and Butterfly Network announce partnership to develop fully non-invasive brain-computer interface: Bridge Neurotech and Butterfly Network announced a partnership to develop a fully non-invasive brain-computer interface. Bridge will license Butterfly’s ultrasound-on-chip under a multi-year agreement with payments and hardware purchases.
| Metric | Value |
|---|---|
| Price | $6.98 |
| Market Cap | $1.80B |
| P/E Ratio | -31.98 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.21 |
| 52-Week Low | $1.32 |
| Volume | 1.05M |
| Avg Volume | 0 |
| Revenue (TTM) | $112.14M |
| Net Income | $-74.85M |
| Gross Margin | 52.64% |
6 analysts cover BFLY: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.